Human Phenotype Ontology 
Grandparent Node:
expand
Abnormality of skin morphology (HP:0011121)help
Parent Node:
expand
Abnormality of skin pigmentation (HP:0001000)help
..Starting node
..expand
Vitiligo (HP:0001045)help
Term ID: 1045
Name: Vitiligo
Synonym: Blotchy loss of skin color; Blotchy loss of skin colour
Definition:
Comments:
Reference: HP:0001045
Genes and Diseases:
 
       Child Nodes:
........expandProgressive vitiligo (HP:0005602) help

 Sister Nodes: 
..expandAbnormality of dermal melanosomes (HP:0011125) help
..expandBlotching pigmentation of the skin (HP:0007610) help
..expandDepigmentation/hyperpigmentation of skin (HP:0007483) help
..expandFine, reticulate skin pigmentation (HP:0007617) help
..expandFreckling (HP:0001480) help
..expandHyperpigmentation of the skin (HP:0000953) help
..expandHypopigmentation of the skin (HP:0001010) help
..expandMelanocytic nevus (HP:0000995) help
..expandMottled pigmentation (HP:0001070) help
..expandNumerous pigmented freckles (HP:0007587) help
..expandPerioral hyperpigmentation (HP:0010802) help
..expandPeriorbital hyperpigmentation (HP:0001106) help
..expandPigmentation anomalies of sun-exposed skin (HP:0007623) help
..expandProfuse pigmented skin lesions (HP:0005587) help
..expandReticulated skin pigmentation (HP:0007427) help
..expandSymmetric great toe depigmentation (HP:0200015) help
InputHPO IDHPO termDistanceGeneGene id entrezHGNC IDDiseaseIdDiseaseNameFrequencyOnsetHGMD variantsClinVar variants
 
HPO disease - gene - phenotype typical associations:
 
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0001045HP:0001045Vitiligo0ACP5 CL E G H54124ORPHA:1855SpondyloenchondrodysplasiaHP:0040284 - Very rare16
HP:0001045HP:0001045Vitiligo0ACP5 CL E G H54124OMIM:607944Spondyloenchondrodysplasia with immune dysregulation.16
HP:0001045HP:0001045Vitiligo0AIRE CL E G H326360OMIM:240300AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE I, WITH OR WITHOUT REVERSIBLE METAPHYSEAL DYSPLASIA; APS192
HP:0001045HP:0001045Vitiligo0CAT CL E G H8471516ORPHA:926AcatalasemiaHP:0040284 - Very rare5
HP:0001045HP:0001045Vitiligo0COX1 CL E G H45127419ORPHA:550MELASHP:0040283 - Occasional
HP:0001045HP:0001045Vitiligo0COX2 CL E G H45137421ORPHA:550MELASHP:0040283 - Occasional
HP:0001045HP:0001045Vitiligo0COX3 CL E G H45147422ORPHA:550MELASHP:0040283 - Occasional
HP:0001045HP:0001045Vitiligo0CTNNBL1 CL E G H5625915879OMIM:619846
HP:0001045HP:0001045Vitiligo0CXCR4 CL E G H78522561ORPHA:51636WHIM syndromeHP:0040284 - Very rare9
HP:0001045HP:0001045Vitiligo0DCLRE1C CL E G H6442117642ORPHA:275Severe combined immunodeficiency due to DCLRE1C deficiencyHP:0040283 - Occasional94
HP:0001045HP:0001045Vitiligo0DSTYK CL E G H2577829043ORPHA:101003Autosomal recessive spastic paraplegia type 23HP:0040282 - Frequent13
HP:0001045HP:0001045Vitiligo0DSTYK CL E G H2577829043OMIM:270750Spastic paraplegia 23.13
HP:0001045HP:0001045Vitiligo0EMC1 CL E G H2306528957ORPHA:480898Global developmental delay-visual anomalies-progressive cerebellar atrophy-truncal hypotonia syndromeHP:0040283 - Occasional5
HP:0001045HP:0001045Vitiligo0FAS CL E G H35511920ORPHA:3437Vogt-Koyanagi-Harada diseaseHP:0040281 - Very frequent59
HP:0001045HP:0001045Vitiligo0FOXD3 CL E G H270223804OMIM:607836Autoimmune disease, susceptibility to, 1.1
HP:0001045HP:0001045Vitiligo0KANSL1 CL E G H28405824565ORPHA:36395817q21.31 microdeletion syndromeHP:0040283 - Occasional283
HP:0001045HP:0001045Vitiligo0KANSL1 CL E G H28405824565ORPHA:363965Koolen-De Vries syndrome due to a point mutationHP:0040283 - Occasional283
HP:0001045HP:0001045Vitiligo0KITLG CL E G H42546343OMIM:145250Hyperpigmentation, familial progressiveHP:0040283 - Occasional9
HP:0001045HP:0001045Vitiligo0LRBA CL E G H9871742OMIM:614700IMMUNODEFICIENCY, COMMON VARIABLE, 8, WITH AUTOIMMUNITY; CVID845
HP:0001045HP:0001045Vitiligo0NBN CL E G H46837652OMIM:251260Nijmegen breakage syndrome706
HP:0001045HP:0001045Vitiligo0ND1 CL E G H45357455ORPHA:550MELASHP:0040283 - Occasional
HP:0001045HP:0001045Vitiligo0ND4 CL E G H45387459ORPHA:550MELASHP:0040283 - Occasional
HP:0001045HP:0001045Vitiligo0ND5 CL E G H45407461ORPHA:550MELASHP:0040283 - Occasional
HP:0001045HP:0001045Vitiligo0ND6 CL E G H45417462ORPHA:550MELASHP:0040283 - Occasional
HP:0001045HP:0001045Vitiligo0NLRP1 CL E G H2286114374OMIM:606579Vitiligo-Associated multiple autoimmune disease susceptibility 1.37
HP:0001045HP:0001045Vitiligo0PLCG2 CL E G H53369066OMIM:614468FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 3; FCAS321
HP:0001045HP:0001045Vitiligo0POGZ CL E G H2312618801ORPHA:468678White-Sutton syndromeHP:0040284 - Very rare35
HP:0001045HP:0001045Vitiligo0PTPN22 CL E G H261919652ORPHA:3437Vogt-Koyanagi-Harada diseaseHP:0040281 - Very frequent3
HP:0001045HP:0001045Vitiligo0SLX4 CL E G H8446423845OMIM:613951Fanconi anemia, complementation group PHP:0040283 - Occasional274
HP:0001045HP:0001045Vitiligo0TRNF CL E G H45587481ORPHA:550MELASHP:0040283 - Occasional
HP:0001045HP:0001045Vitiligo0TRNH CL E G H45647487ORPHA:550MELASHP:0040283 - Occasional
HP:0001045HP:0001045Vitiligo0TRNL1 CL E G H45677490ORPHA:550MELASHP:0040283 - Occasional
HP:0001045HP:0001045Vitiligo0TRNQ CL E G H45727495ORPHA:550MELASHP:0040283 - Occasional
HP:0001045HP:0001045Vitiligo0TRNS1 CL E G H45747497ORPHA:550MELASHP:0040283 - Occasional
HP:0001045HP:0001045Vitiligo0TRNS2 CL E G H45757498ORPHA:550MELASHP:0040283 - Occasional
HP:0001045HP:0001045Vitiligo0TRNW CL E G H45787501ORPHA:550MELASHP:0040283 - Occasional
HP:0001045HP:0005602Progressive vitiligo1NBN CL E G H46837652OMIM:251260Nijmegen breakage syndrome.706


Genes (33) :ACP5 AIRE CAT COX1 COX2 COX3 CTNNBL1 CXCR4 DCLRE1C DSTYK EMC1 FAS FOXD3 KANSL1 KITLG LRBA NBN ND1 ND4 ND5 ND6 NLRP1 PLCG2 POGZ PTPN22 SLX4 TRNF TRNH TRNL1 TRNQ TRNS1 TRNS2 TRNW

Diseases (22) :ORPHA:1855 OMIM:607944 OMIM:240300 ORPHA:926 ORPHA:550 OMIM:619846 ORPHA:51636 ORPHA:275 ORPHA:101003 OMIM:270750 ORPHA:480898 ORPHA:3437 OMIM:607836 ORPHA:363958 ORPHA:363965 OMIM:145250 OMIM:614700 OMIM:251260 OMIM:606579 OMIM:614468 ORPHA:468678 OMIM:613951
 

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is December 15 2022 release.